naltrexone and Bulimia

naltrexone has been researched along with Bulimia in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19904 (16.67)18.7374
1990's9 (37.50)18.2507
2000's5 (20.83)29.6817
2010's5 (20.83)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Billman, M; Essayli, J; Lane-Loney, S; Mahr, F; Roden, RC; Ryan, S; Vrana, K1
Adam, T; Dallman, M; Daubenmier, J; Epel, E; Hecht, FM; Kristeller, J; Lustig, RH; Woolley, J1
Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ1
Kim, JJ; Lardeux, S; Nicola, SM1
Hackett, D; Heal, DJ; Hutson, PH; Murray, F; Vickers, SP1
Fontenelle, LF; Piquet-Pessôa, M1
Meyer, F1
Jarosz, PA; Metzger, BL1
Bringer, J; Courtet, P; Raingeard, I; Renard, E1
Capone, C; Farren, CK; Grilo, CM; McKee, SA; O'Malley, SS; Rounsaville, BJ; Sinha, R; Wu, R1
Corwin, RL; Coupland, J; Ghosh, S; Rao, RE; Wojnicki, FH1
Kinzie, J; Luby, ED; Markham, KM; Marrazzi, MA1
Chatoor, I; Hartzler, J; Herman, BH1
Mitchell, JE; Raymond, N; Specker, S1
Bacon, JP; Kinzie, J; Luby, ED; Marrazzi, MA1
Kinzie, J; Luby, ED; Marrazzi, MA1
Kinzie, J; Luby, ED; Marrazzi, MA; Wroblewski, JM1
Fornai, F; Maremmani, I; Marini, G1
Neumeister, A; Winkler, A; Wöber-Bingöl, C1
Alger, SA; Bigaouette, JM; Howard, LJ; Michalek, AV; Schwalberg, MD1
Christenson, G; Huber, M; Jennings, J; Mitchell, JE; Morley, J; Pomeroy, C; Thomas, B1
Gold, MS; Jonas, JM2
Apfelbaum, M; Igoin-Apfelbaum, L1

Reviews

2 review(s) available for naltrexone and Bulimia

ArticleYear
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6

    Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania

2016
A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa.
    The International journal of eating disorders, 1993, Volume: 14, Issue:3

    Topics: Antidepressive Agents; Bulimia; Clinical Trials as Topic; Cognitive Behavioral Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithium Carbonate; Naltrexone

1993

Trials

12 trial(s) available for naltrexone and Bulimia

ArticleYear
An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.
    Contemporary clinical trials, 2022, Volume: 122

    Topics: Adolescent; Anorexia Nervosa; Binge-Eating Disorder; Bulimia; Bulimia Nervosa; Feeding and Eating Disorders; Humans; Naltrexone; Randomized Controlled Trials as Topic; Young Adult

2022
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
    Appetite, 2015, Volume: 91

    Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs

2015
Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.
    Diabetes care, 2004, Volume: 27, Issue:3

    Topics: Blood Glucose; Bulimia; Diabetes Mellitus, Type 1; Energy Intake; Feeding and Eating Disorders; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Naltrexone; Narcotic Antagonists; Time Factors

2004
Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    Alcoholism, clinical and experimental research, 2007, Volume: 31, Issue:4

    Topics: Adaptation, Psychological; Adult; Alcohol Drinking; Alcoholism; Attitude; Body Mass Index; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Feeding and Eating Disorders; Female; gamma-Glutamyltransferase; Humans; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Treatment Outcome

2007
Binge eating disorder: response to naltrexone.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1995, Volume: 19, Issue:2

    Topics: Adult; Bulimia; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Naltrexone; Placebos

1995
Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:5

    Topics: Adolescent; beta-Endorphin; Bulimia; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Motivation; Naltrexone; Patient Admission; Psychotherapy; Single-Blind Method; Thinking

1994
Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa.
    International clinical psychopharmacology, 1995, Volume: 10, Issue:3

    Topics: Adult; Anorexia Nervosa; Body Weight; Bulimia; Follow-Up Studies; Humans; Naltrexone; Placebo Effect; Time Factors; Treatment Outcome

1995
A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia.
    International clinical psychopharmacology, 1995, Volume: 10, Issue:3

    Topics: Adult; Bulimia; Feeding and Eating Disorders; Female; Follow-Up Studies; Humans; Longitudinal Studies; Naltrexone; Treatment Outcome

1995
High-dose naltrexone and liver function safety.
    The American journal on addictions, 1997,Winter, Volume: 6, Issue:1

    Topics: Adult; Alanine Transaminase; Anorexia Nervosa; Aspartate Aminotransferases; Bulimia; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists

1997
Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects.
    The American journal of clinical nutrition, 1991, Volume: 53, Issue:4

    Topics: Adult; beta-Endorphin; Bulimia; Double-Blind Method; Female; Humans; Hyperphagia; Imipramine; Naltrexone; Obesity

1991
A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:2

    Topics: Adult; Bulimia; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Naltrexone; Psychiatric Status Rating Scales; Random Allocation

1989
Naltrexone and bulimic symptoms.
    Lancet (London, England), 1987, Nov-07, Volume: 2, Issue:8567

    Topics: Adolescent; Adult; Bulimia; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Naltrexone

1987

Other Studies

10 other study(ies) available for naltrexone and Bulimia

ArticleYear
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.
    Appetite, 2014, Volume: 74

    Topics: Adiposity; Adult; Biomarkers; Body Mass Index; Bulimia; Cross-Sectional Studies; Eating; Energy Intake; Feeding Behavior; Female; Humans; Hydrocortisone; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Overweight; Receptors, Opioid; Surveys and Questionnaires

2014
Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.
    Behavioural brain research, 2015, Oct-01, Volume: 292

    Topics: Analgesics, Opioid; Animals; Bulimia; Diet, High-Fat; Eating; Male; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats, Long-Evans; Receptors, Dopamine; Receptors, Opioid; Synaptic Transmission

2015
Effects of lisdexamfetamine in a rat model of binge-eating.
    Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:12

    Topics: Animals; Baclofen; Behavior, Animal; Benzazepines; Benzodiazepines; Body Weight; Bulimia; Disease Models, Animal; Eating; Feeding Behavior; Female; Idazoxan; Lisdexamfetamine Dimesylate; Naltrexone; Olanzapine; Prazosin; Prodrugs; Raclopride; Rats; Rats, Wistar; Rolipram

2015
Alleviation of both binge eating and sexual dysfunction with naltrexone.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: Alcoholism; Antidepressive Agents; Bulimia; Child; Child Abuse; Depression; Female; Heroin Dependence; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Sex Work; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Stress Disorders, Post-Traumatic

2008
The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
    Biological research for nursing, 2002, Volume: 3, Issue:4

    Topics: Animals; Body Weight; Brain; Bulimia; Energy Intake; Feeding Behavior; Hyperphagia; Injections, Intraventricular; Models, Animal; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Zucker; Satiation

2002
Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 89, Issue:4

    Topics: Animals; Baclofen; Bulimia; Dietary Fats; Dopamine Antagonists; Eating; Emulsions; Feeding Behavior; GABA Agonists; Male; Naltrexone; Narcotic Antagonists; Raclopride; Rats; Rats, Sprague-Dawley

2008
Naltrexone-induced panic attacks.
    The American journal of psychiatry, 1998, Volume: 155, Issue:3

    Topics: Adult; Bulimia; Female; Humans; Naltrexone; Panic Disorder

1998
Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
    The American journal of psychiatry, 1999, Volume: 156, Issue:5

    Topics: Adolescent; Bulimia; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors

1999
Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse.
    Advances in alcohol & substance abuse, 1987, Volume: 7, Issue:1

    Topics: Adult; Brain; Bulimia; Feeding Behavior; Female; Humans; Naltrexone; Receptors, Opioid; Substance-Related Disorders

1987
The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone.
    Psychiatry research, 1988, Volume: 24, Issue:2

    Topics: Bulimia; Dose-Response Relationship, Drug; Humans; Naltrexone; Receptors, Opioid

1988